- Home
- BXSL vs CORT Comparison
BXSL vs CORT Comparison
Compare BXSL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXSL
- CORT
- Stock Information
- Founded
- BXSL 2018
- CORT 1998
- Country
- BXSL United States
- CORT United States
- Employees
- BXSL N/A
- CORT N/A
- Industry
- BXSL Trusts Except Educational Religious and Charitable
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- BXSL Finance
- CORT Health Care
- Exchange
- BXSL Nasdaq
- CORT Nasdaq
- Market Cap
- BXSL 7.3B
- CORT 7.6B
- IPO Year
- BXSL N/A
- CORT N/A
- Fundamental
- Price
- BXSL $27.73
- CORT $69.53
- Analyst Decision
- BXSL Buy
- CORT Strong Buy
- Analyst Count
- BXSL 7
- CORT 4
- Target Price
- BXSL $31.32
- CORT $139.00
- AVG Volume (30 Days)
- BXSL 1.3M
- CORT 644.6K
- Earning Date
- BXSL 11-11-2025
- CORT 10-29-2025
- Dividend Yield
- BXSL 11.11%
- CORT N/A
- EPS Growth
- BXSL N/A
- CORT N/A
- EPS
- BXSL 2.83
- CORT 1.11
- Revenue
- BXSL $1,398,444,000.00
- CORT $716,080,000.00
- Revenue This Year
- BXSL $4.83
- CORT $30.62
- Revenue Next Year
- BXSL $3.95
- CORT $37.68
- P/E Ratio
- BXSL $9.81
- CORT $62.97
- Revenue Growth
- BXSL 14.70
- CORT 25.71
- 52 Week Low
- BXSL $25.89
- CORT $37.82
- 52 Week High
- BXSL $34.64
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- BXSL 19.59
- CORT 45.26
- Support Level
- BXSL $28.38
- CORT $67.32
- Resistance Level
- BXSL $29.57
- CORT $74.79
- Average True Range (ATR)
- BXSL 0.42
- CORT 2.36
- MACD
- BXSL -0.11
- CORT 0.14
- Stochastic Oscillator
- BXSL 1.67
- CORT 29.58
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.